Evommune, Inc. (EVMN) dividend history

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30

$7.63−0.39 (-4.86%)

Close on Nov 13, 2026Market cap $276.91MP/E –Yield –

Dividends

Evommune has not reported a dividend

No dividend per share appears in Evommune's annual filings since fiscal 2023.

Where these numbers come from

Parsed from the XBRL in Evommune's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVMN.

Compare: EVMN vs HCWB · EVMN vs ALMS · EVMN vs ZBIO · EVMN vs ACRS · EVMN vs EQ

Revenue growth-100.0% · median 320.4%

Company	Revenue	Growth
ALMS	$7.24M	–
HCWB	$6.66M	+700.2%
ACRS	$6.40M	-59.3%
EVMN	$0	-100.0%
ZBIO	–	–
EQ	–	–

Company

Next earnings (est.): Mar 4, 2027, after close
Exchange: NYSE
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 48
Held by institutions: 95.4%
Auditor: BDO USA, P.C
SEC CIK: 2044725

Advertisement
300 × 250

See a number that looks wrong?